Feedback / Questions
FB-102 - Forte Biosci
https://www.globenewswire.com/news-release/2026/07/27/3333257/0/en/argenx-to-Acquire-Forte-Biosciences-Inc-Adding-First-in-Class-anti-CD122-Antibody-FB102-to-its-Immunology-Pipeline.html
Jul 27, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next